Please login to the form below
drug launch
This page shows the latest drug launch news and features for those working in and with pharma, biotech and healthcare.
Bristol Myers Squibb launches initiative to ensure disability diversity in clinical trials
Commenting on the launch, Tinamarie Duff, DAWN global people and business resource group lead, BMS, said: “People with disabilities are omitted from conversations about diversity and inclusion, despite being the largest ... The launch of the DDiCT,
Latest news
-
Kite’s new CAR T-cell therapy manufacturing facility given the go-ahead by the FDA
Kite, a Gilead Company, has announced that the US Food and Drug Administration (FDA) has approved the launch of commercial production at its new CAR T-cell therapy manufacturing facility.
-
First trial of a vaccine against Alzheimer’s launches
However, there has been renewed interest across the industry in recent years, culminating in the approval of the first treatment for Alzheimer’s disease, Aduhelm, although the drug’s launch has ... Earlier this week, following reports of the death of
-
Embattled Biogen talks up Aduhelm
They are: to improve understanding of Aduhelm clinical data across the board, to expedite the development of the infrastructure necessary to launch the drug and to seek to clarify the reimbursement ... The number of doctors that are currently prescribing
-
Lilly restructures in preparation for Alzheimer’s drug launch
As excitement builds around its potential Alzheimer’s drug, donanemab, Lilly has created a new neuroscience business unit, Lilly Neuroscience, to shepherd the company’s portfolio in pain and neurodegeneration. ... This includes the company’s
-
Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
Encouraged and spurred on by the initial efficacy of Actemra, Kevzara’s owners are carrying out their own trials of the drug as a treatment for the novel coronavirus, with Regeneron ... 16 sites and evaluating the drug’s effect on fever and
More from news
Approximately 1 fully matching, plus 207 partially matching documents found.
Latest Intelligence
-
Listen, learn and lift off
more fluid internal collaborations that can help organisations work in sync and move beyond well-thumbed launch playbooks. ... Learning from the HCP feedback is ultimately where we see the shift in terms of launch success.
-
The secret to a successful brand launch: being in it together
There are many insights, recommendations and strategies about what the ingredients for a successful launch are, yet nearly 50% of drug launches underperform against expectations. ... Agencies are in a rare position, having honed and evolved their launch
-
Reaching patients and HCPs during the pandemic
Nexlizet, and Esperion was even able to accelerate the launch of the therapy by one month. ... While Horizon was fortunate enough to launch its bulging eye drug, Tepezza, in January 2020, the pandemic still hit at a critical time for any new drug.
-
Successful product commercialisation: what can we learn from the rare disease setting?
Achieving launch success in an increasingly challenging commercial environment. The pharmaceutical industry is constantly evaluating opportunities to accelerate product life cycles and bring efficiencies to drug discovery, development and
-
Alzheimer’s: the search for a cure
However, the situation has changed dramatically since then, with Biogen preparing for a drug launch that could make aducanumab a blockbuster and reinvigorate interest in amyloid beta. ... A lot is resting on the US Food and Drug Administration’s (FDA)
More from intelligence
Approximately 1 fully matching, plus 19 partially matching documents found.
Latest appointments
-
NDA Group appoints Alison McGregor as its principal consultant
She joins the group following a new US office launch. Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office
-
Medicines Discovery Catapult appoints CEO
Chris' experience of leading companies operating in life sciences combined with his in-depth knowledge of drug discovery will be of tremendous value to the company.”. ... The Catapult will engage the UK's experienced drug discovery talent and help
-
Astellas promotes John Demaree
Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).
-
Paolo Paoletti named as executive chairman of Kesios
Paoletti was formerly the first appointed president of GSK Oncology, where he was responsible for the overall oncology business within the firm and oversaw activities from early drug discovery through to ... clinical development, launch and life cycle
-
Purdue looks to Merck for new CEO
His previous roles include president of Merck US, during which time he helped to launch the hepatitis C drug Victrelis (boceprevir) and led the acquisition of ophthalmology company Inspire Pharmaceuticals.
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
AMICULUM® collaborates with the University of Dundee to develop a new Master’s course in Science and Health Communication
The AMICULUM team worked closely with the Schools of Life Sciences and Medicine at the University to develop the concept and to prepare for the launch of the course in September ... Understanding the drug lifecycle (pre- and post-launch), as well as
-
Learning and development: the secret weapon for a successful life science launch
A recent study by McKinsey &Associates estimates nearly 2/3 of all new drug launches miss their pre‑launch sales targets in the first year. ... a launch training plan than traditional topics like disease state and mechanism of action.
-
Nucleus X Consulting – where patient engagement meets strategic consultancy
The challenges associated with a rare disease drug launch are well documented: awareness of the disease and symptoms remain low, the diagnostic pathway can be long (and fraught with misdiagnosis), few ... Typically, these journeys are long and challenging
-
6 critical success factors for flawless execution of a rapid first commercial launch
The success of any drug launch begins long before a regulatory agency gives the product the green light. ... Disconnects can be surfaced by the launch readiness team with the help of their partners.
-
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? ... COVID’s impact on financial performance is estimated to be a 9% decrease in launch drug value - an overall loss of $10 billion globally.
More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Create Health
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
